173 related articles for article (PubMed ID: 29544697)
1. The expression of p-mTOR and COUP-TFII correlates with increased lymphangiogenesis and lymph node metastasis in prostate adenocarcinoma.
Lilis I; Giopanou I; Papadaki H; Gyftopoulos K
Urol Oncol; 2018 Jun; 36(6):311.e27-311.e35. PubMed ID: 29544697
[TBL] [Abstract][Full Text] [Related]
2. Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression.
Nagasaki S; Suzuki T; Miki Y; Akahira J; Shibata H; Ishida T; Ohuchi N; Sasano H
Cancer Sci; 2009 Apr; 100(4):639-45. PubMed ID: 19154418
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
4. Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development.
Lin FJ; Chen X; Qin J; Hong YK; Tsai MJ; Tsai SY
J Clin Invest; 2010 May; 120(5):1694-707. PubMed ID: 20364082
[TBL] [Abstract][Full Text] [Related]
5. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
6. Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
Chen H; Guan R; Lei Y; Chen J; Ge Q; Zhang X; Dou R; Chen H; Liu H; Qi X; Zhou X; Chen C
BMC Cancer; 2015 Mar; 15():103. PubMed ID: 25884175
[TBL] [Abstract][Full Text] [Related]
7. COUP-TFII in pancreatic adenocarcinoma: clinical implication for patient survival and tumor progression.
Polvani S; Tarocchi M; Tempesti S; Mello T; Ceni E; Buccoliero F; D'Amico M; Boddi V; Farsi M; Nesi S; Nesi G; Milani S; Galli A
Int J Cancer; 2014 Apr; 134(7):1648-58. PubMed ID: 24122412
[TBL] [Abstract][Full Text] [Related]
8. Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer.
Hong KD; Lee Y; Kim BH; Lee SI; Moon HY
Am Surg; 2013 Feb; 79(2):198-204. PubMed ID: 23336661
[TBL] [Abstract][Full Text] [Related]
9. COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1.
Bao Y; Gu D; Feng W; Sun X; Wang X; Zhang X; Shi Q; Cui G; Yu H; Tang C; Deng A
Br J Cancer; 2014 Aug; 111(5):933-43. PubMed ID: 25032732
[TBL] [Abstract][Full Text] [Related]
10. MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer.
Wang L; Xu M; Qin J; Lin SC; Lee HJ; Tsai SY; Tsai MJ
Oncotarget; 2016 Mar; 7(12):14673-83. PubMed ID: 26895100
[TBL] [Abstract][Full Text] [Related]
11. Twist modulates lymphangiogenesis and correlates with lymph node metastasis in supraglottic carcinoma.
Lu SM; Yu L; Tian JJ; Ma JK; Li JF; Xu W; Wang HB
Chin Med J (Engl); 2011 May; 124(10):1483-7. PubMed ID: 21740802
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer.
Arigami T; Natsugoe S; Uenosono Y; Yanagita S; Ehi K; Arima H; Mataki Y; Nakajo A; Ishigami S; Aikou T
J Surg Oncol; 2009 Mar; 99(3):148-53. PubMed ID: 19117016
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
[TBL] [Abstract][Full Text] [Related]
14. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
Qin J; Wu SP; Creighton CJ; Dai F; Xie X; Cheng CM; Frolov A; Ayala G; Lin X; Feng XH; Ittmann MM; Tsai SJ; Tsai MJ; Tsai SY
Nature; 2013 Jan; 493(7431):236-40. PubMed ID: 23201680
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic vessel densities of lymph node-negative prostate adenocarcinoma in Korea.
Kim HS; Sung W; Lee S; Chang SG; Park YK
Pathol Res Pract; 2009; 205(4):249-54. PubMed ID: 19058917
[TBL] [Abstract][Full Text] [Related]
16. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factors C and D correlates with lymphangiogenesis and lymph node metastasis in lung adenocarcinoma.
Bo C; Xiaopeng D; Chuanliang P; Xiaogang Z
Thorac Cardiovasc Surg; 2009 Aug; 57(5):291-4. PubMed ID: 19629892
[TBL] [Abstract][Full Text] [Related]
18. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.
Qin J; Chen X; Yu-Lee LY; Tsai MJ; Tsai SY
Cancer Res; 2010 Nov; 70(21):8812-21. PubMed ID: 20978203
[TBL] [Abstract][Full Text] [Related]
19. Changes in Lymphangiogenesis and Vascular Endothelial Growth Factor Expression by Neo-Adjuvant Hormonal Therapy in Prostate Cancer Patients.
Asai A; Miyata Y; Matsuo T; Shida Y; Hakariya T; Ohba K; Sakai H
Prostate; 2017 Feb; 77(3):255-262. PubMed ID: 27527525
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.
Kobayashi S; Kishimoto T; Kamata S; Otsuka M; Miyazaki M; Ishikura H
Cancer Sci; 2007 May; 98(5):726-33. PubMed ID: 17425689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
